Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
From ‘Project Hail Mary’ to Artemis II, spaceflight captures audiences when it centers on people because human space travel is hazardous - 2Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
- 3Well known SUVs With Low Energy Utilization In 2024 vote
- 4Visiting This Japanese City Just Got A Little More Expensive (Here's What Travelers Should Know)
- 5Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
- Holyvolt And Wildcat Could Help The West Reclaim Battery Leadership
- Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- Vote In favor of Your Favored Menial helper Administration
- 6 Nations for Setting up camp
- Volunteers aiding humpback whale stranded in Baltic get death threats
- Best Getaway destination: Ocean side, Mountain, or City
- Vote In favor of Your Favored Kind Of Attire
- Why this Iranian island looks like Mars after it rains
